Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany 600x60px
Organisation › Details

Basilea Pharmaceutica Ltd. (SIX: BSLN)

Basilea Pharmaceutica Ltd. is an integrated biopharmaceutical company headquartered in Basel, Switzerland, listed on the SWX Swiss Exchange (SWX:BSLN). Basilea is currently focused on the research, development and commercialization of new antibacterial, antifungal and dermatology drugs in the hospital and specialty care setting. *

 

Period Start 2000-10-01 splitoff
  Group Basilea (Group)
  Predecessor Roche (Group)
Products Industry antibiotic
  Industry 2 dermatic
Persons Person Scott, Ronald (Ron) (Basilea 201212–201804 CEO before COO before CFO RETIRED 2/18 proposed for Board)
  Person 2 Blatter, Joachim (Basilea 201201– CFO before Swissmetal Industries)
     
Region Region Basel BS
  Country Switzerland
  Street 487 Grenzacherstr.
  City 4058 Basel BS
  Tel +41-61-606-1111
    Address record changed: 2018-07-24
     
Basic data Employees D: 101 to 500 (2017-12-31)
  Currency CHF
  Annual sales 101,521,000 (revenue, total, consolidated (2017) 2017-12-31)
  Profit -19,360,000 (2017-12-31)
  Cash 200,724,000 (2017-12-31)
     
    * Document for �About Section�: 
     
   
Record changed: 2018-04-29

Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany iito 600x60px

More documents for Basilea (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany 600x60px




» top